Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Molecular Mechanisms of COPD Exacerbations. Effect of Low-Dose Theophylline

NCT00671151 is registered in ClinicalTrials.gov with Hospital Universitari Son Dureta as lead sponsor.

NCT NCT00671151
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00671151 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Molecular Mechanisms of COPD Exacerbations. Effect of Low-Dose Theophylline
Lead sponsor
Hospital Universitari Son Dureta
Phase
Not applicable
Overall status
Completed
Start date
June 30, 2005
Completion date
December 31, 2007
Enrollment
35 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

copd